Foresight in laryngology and laryngeal surgery: A 2020 vision

Annals of Otology, Rhinology and Laryngology

Volumn 116, Issue 9 II, 2007, Pages 1-16

  Zeitels, Steven M ^a,b   Blitzer, Andrew ^c   Hillman, Robert E ^a,b   Anderson, R Rox ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cancer; Glottis; Laryngology; Laryngoscopy; Larynx; Laser; Vocal cord; Vocal fold; Voice

Indexed keywords

CHEMOSURGERY; DYSPHONIA; ENDOSCOPIC SURGERY; GENERAL ANESTHESIA; GENETIC MANIPULATION; HUMAN; INTRAVENOUS ANESTHESIA; LARYNX CARCINOMA; LARYNX SURGERY; LASER SURGERY; LOCAL ANESTHESIA; MEDICAL RESEARCH; MEDICAL SOCIETY; MINIMALLY INVASIVE SURGERY; MOUTH CAVITY; NOSE; PHARYNX; PHONATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SURGICAL APPROACH; SURGICAL TECHNIQUE; TECHNOLOGY; TOPICAL ANESTHESIA; TREATMENT INDICATION; AMBULATORY CARE; ARTICLE; EAR NOSE THROAT SURGERY; FORECASTING; LARYNGOSCOPY; LARYNX; LARYNX DISORDER; LARYNX PROSTHESIS; LOW LEVEL LASER THERAPY; MICROSCOPY; NEUROLOGIC DISEASE; OTORHINOLARYNGOLOGY; PHOTOCHEMOTHERAPY; ROBOTICS;

AMBULATORY CARE; FORECASTING; HUMANS; LARYNGEAL DISEASES; LARYNGOSCOPY; LARYNX; LARYNX, ARTIFICIAL; LASER THERAPY; MICROSCOPY; NERVOUS SYSTEM DISEASES; OTOLARYNGOLOGY; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; PHOTOCHEMOTHERAPY; ROBOTICS;

EID: 34548864126     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940711600901     Document Type: Review

References (102)

1. Jackson C. Hindsight. Reprint: Graduation Address 1925, Woman's Medical College of Pennsylvania, 1925.
2. Lewin G. Allgemeine Medizinische Central-Zeitung, 1861;XXX:654.
3. Mackenzie M. The extirpation of growths. In: The use of the laryngoscope in diseases of the throat with an appendix on rhinoscopy. Churchill, London: J & A, 1865:121-8.
4. Eisberg L. Laryngoscopal surgery illustrated in the treatment of morbid growths within the larynx. Philadelphia, Pa: Collins, 1866.
5. Solis-Cohen J. Removal of a fibrous polyp from the inferior surface of the right vocal fold with the aid of the laryngoscope. Am J Med Sci 1867;April:404-7.
6. Koller K. Ueber die Verwendung des Cocain zur Anasthesirung am Aug. Wien Med Wochenschr 1884;34:1276.
7. Jelinek E. Das Cocain als Anastheticum und Analgeticum fur den Pharynx und Larynx. Wien Med Wochenschr 1884; 45:1334-7, 1364-7.
8. O'Dwyer J. Chronic Stenosis of the larynx treated by a new method. NY Med Rec 1886;June 5.
9. O'Dwyer J. Intubation for chronic stenosis of the larynx. NY Med J 1888;March 10.
10. Kirstein A. Autoskopie des Larynx und der Trachea (Laryngoscopia directa, Euthyskopie, Besichtigung ohne Spiegel). Arch Laryngol Rhinol 1895;3:156-64.
11. Kirstein A. Autoscopy of the larynx and trachea (direct examination without mirror). Philadelphia, Pa: FA Davis Co, 1897.
12. Zeitels SM, Franco RA Jr, Dailey SH, Burns JA, Hillman RE, Anderson RR. Office-based treatment of glottal dysplasia and papillomatosis with the 585-nm pulsed dye laser and local anesthesia. Ann Otol Rhinol Laryngol 2004;113:265-76.
13. Bastian RW, Delsupehe KG. Indirect larynx and pharynx surgery: a replacement for direct laryngoscopy. Laryngoscope 1996;106:1280-6.
14. Omori K, Shinohara K, Tsuji T, Kojima H. Videoendoscopic laryngeal surgery. Ann Otol Rhinol Laryngol 2000;109: 149-55.
15. Blitzer A, Brin MF, Fahn S, Lovelace RE. Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases. Laryngoscope 1988;98:636-40.
16. Blitzer A, Brin MF, Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 1998;108: 1435-41.
17. Ford CN, Bless DM. Clinical experience with injectable collagen for vocal fold augmentation. Laryngoscope 1986;96: 863-9.
18. Ford CN. A multipurpose laryngeal injector device. Otolaryngol Head Neck Surg 1990;103:135-7.
19. Aviv JE, Kim T, Thomson JE, Sunshine S, Kaplan S, Close LG. Fiberoptic endoscopic evaluation of swallowing with sensory testing (FEESST) in healthy controls. Dysphagia 1998; 13:87-92.
20. Aviv JE, Murry T, Zschommler A, Cohen M, Gartner C. Flexible endoscopic evaluation of swallowing with sensory testing: patient characteristics and analysis of safety in 1,340 consecutive examinations. Ann Otol Rhinol Laryngol 2005;114: 173-6.
21. Zeitels SM, Burns JA. Laser applications in laryngology: past, present, and future. Otolaryngol Clin North Am 2006; 39:159-72.
22. Zeitels SM, Akst LM, Burns JA, Hillman RE, Broadhurst MS, Anderson RR. Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. Ann Otol Rhinol Laryngol 2006;115:679-85.
23. Green H. A treatise on diseases of the air passages. New York, NY: Wiley and Putnam, 1846.
24. Green H. On the subject of the priority in the medication of the larynx and trachea. Am Med Monthly 1854;1:241-57.
25. Green H. Report on the use and effect of applications of nitrate silver to the throat, either in local or general disease. Trans Am Med Assoc 1856;9:493-530.
26. Eisberg L. Laryngoscopal medication or the local treatment of the diseases of the throat, larynx, and neighboring organs, under sight. New York, NY: William Wood & Co, 1864.
27. Gray SD, Hammond E, Hanson DF. Benign pathologic responses of the larynx. Ann Otol Rhinol Laryngol 1995;104:13-8.
28. Gray S. Basement membrane zone injury in vocal nodules. In: Gauffin J, Hammarberg B, eds. Vocal fold physiology. San Diego, Calif: Singular Press, 1991.
29. Smith ME, Marsh JH, Cotton RT, Myer CM III. Voice problems after pediatric laryngotracheal reconstruction: videolaryngostroboscopic, acoustic, and perceptual assessment. Int J Pediatr Otorhinolaryngol 1993;25:173-81.
30. MacArthur CJ, Kearns GH, Healy GB. Voice quality after laryngotracheal reconstruction. Arch Otolaryngol Head Neck Surg 1994;120:641-7.
31. Gray SD, Titze IR, Alipour F, Hammond TH. Biomechanical and histologic observations of vocal fold fibrous proteins. Ann Otol Rhinol Laryngol 2000;109:77-85.
32. Gray S, Titze IR, Chan R. Vocal fold proteoglycans and their influence on biomechanics. Laryngoscope 1999;109:845-54.
33. Chan R, Gray SD, Titze IR. The importance of hyaluronic acid in vocal fold biomechanics. Otolaryngol Head Neck Surg 2001;124:607-14.
34. Hahn MS, Kobler JB, Zeitels SM, Langer R. Quantitative and comparative studies of the vocal fold extracellular matrix. II: Collagen. Ann Otol Rhinol Laryngol 2006;115:225-32.
35. Hahn MS, Kobler JB, Zeitels SM, Langer R. Midmembranous vocal fold lamina propria proteoglycans across selected species. Ann Otol Rhinol Laryngol 2005;114:451-62.
36. Vacanti JP, Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 1999;354(suppl):S132-S134.
37. Hahn MS, Teply BA, Stevens MM, Zeitels SM, Langer R. Collagen composite hydrogels for vocal fold lamina propria restoration. Biomaterials 2006;27:1104-9.
38. Chan RW, Titze IR. Hyaluronic acid (with fibronectin) as a bioimplant for the vocal fold mucosa. Laryngoscope 1999; 109:1142-9.
39. Jako GJ, Kleinsasser O. Endolaryngeal micro-diagnosis and microsurgery. Reprint from the Annual Meeting of the American Medical Association, 1966.
40. Zeitels SM, Anderson RR, Hillman RE. 585-nm Pulsed-dye laser treatment of glottal cancer: proof of concept and a possible harbinger of future treatment philosophy [Abstract]. Trans Am Broncho Esophagol Assoc 2004:171.
41. Snoeck R, Wellens W, Desloovere C, et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2- phosphonylmethoxypropyl)-cytosine]. J Med Virol 1998;54:219-25.
42. Spector JE, Werkhaven JA, Spector NC, Huang S, Sanders D, Reinisch L. Prevention of anterior glottic restenosis in a canine model with topical mitomycin-C. Ann Otol Rhinol Laryngol 2001;110:1007-10.
43. Spector JE, Werkhaven JA, Spector NC, et al. Preservation of function and histologic appearance in the injured glottis with topical mitomycin-C. Laryngoscope 1999;109:1125-9.
44. Santini JT Jr, Richards AC, Scheidt RA, Cima MJ, Langer RS. Microchip technology in drug delivery. Ann Med 2000; 32:377-9.
45. Ohye C, Shibazaki T, Sato S. Gamma knife thalamotomy for movement disorders: evaluation of the thalamic lesion and clinical results. J Neurosurg 2005;102(suppl):234-40.
46. Raso VV, Barbieri CH, Mazzer N, Fasan VS. Can therapeutic ultrasound influence the regeneration of peripheral nerves? J Neurosci Methods 2005;142:185-92.
47. Shapiro S, Borgens R, Pascuzzi R, et al. Oscillating field stimulation for complete spinal cord injury in humans: a phase 1 trial. J Neurosurg Spine 2005;2:3-10.
48. De Pedro JA, Perez-Caballer AJ, Dominguez J, Collia F, Blanco J, Salvado M. Oscillating field stimulation for complete spinal cord injury in humans: a phase 1 trial. Bioelectromagnetics 2005;26:20-7.
49. Fraix V, Pollak P, Moro E, et al. Subthalamic nucleus stimulation in tremor dominant parkinsonian patients with previous thalamic surgery. J Neurol Neurosurg Psychiatry 2005;76: 246-8.
50. Vidailhet M, Vercueil L, Houeto JL, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 2005;352:459-67.
51. Montgomery EB Jr. Deep brain stimulation for hyperkinetic disorders. Neurosurg Focus 2004;17:E1.
52. Broniatowski M. Bionic larynx: electronic control of the reimplanted organ in the dog. Laryngoscope 1988;98:1107-15.
53. Zealear DL, Rainey CL, Netterville JL, Herzon GD, Ossoff RH. Electrical pacing of the paralyzed human larynx. Ann Otol Rhinol Laryngol 1996;105:689-93.
54. Blitzer A, Sulica L. Botulinum toxin: basic science and clinical uses in otolaryngology. Laryngoscope 2001;111:218-26.
55. Stix G. A toxin against pain. Sci Am 2005;292:70-5.
56. Doss MX, Koehler CI, Gissel C, Hescheler J, Sachinidis A. Embryonic stem cells: a promising tool for cell replacement therapy. J Cell Mol Med 2004;8:465-73.
57. Yasuhara T, Shingo T, Muraoka K, et al. Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease. J Neurosurg 2005;102: 80-9.
58. Berry M, Barrett L, Seymour L, Baird A, Logan A. Gene therapy for central nervous system repair. Curr Opin Mol Ther 2001;3:338-49.
59. Breakefield XO, DeLuca NA. Herpes simplex virus for gene delivery to neurons. New Biol 1991;3:203-18.
60. White WM, Baldassano M, Rajadhyaksha M, et al. Confocal reflectance imaging of head and neck surgical specimens. A comparison with histologic analysis. Arch Otolaryngol Head Neck Surg 2004;130:923-8.
61. Bibas AG, Podoleanu AG, Cucu RG, et al. 3-D optical coherence tomography of the laryngeal mucosa. Clin Otolaryngol Allied Sci 2004;29:713-20.
62. Burns JA, Zeitels SM, Anderson RR, Kobler JB, Pierce MC, de Boer JF. Imaging the mucosa of the human vocal fold with optical coherence tomography. Ann Otol Rhinol Laryngol 2005;114:671-6.
63. Nassif NA, Armstrong WB, de Boer JF, Wong BJ. Measurement of morphologic changes induced by trauma with the use of coherence tomography in porcine vocal cords. Otolaryngol Head Neck Surg 2005;133:845-50.
64. Wong BJ, Jackson RP, Guo S, et al. In vivo optical coherence tomography of the human larynx: normative and benign pathology in 82 patients. Laryngoscope 2005;115:1904-11. [Erratum in Laryngoscope 2006;116:507.]
65. Klein AM, Pierce MC, Zeitels SM, et al. Imaging the human vocal folds in vivo with optical coherence tomography: a preliminary experience. Ann Otol Rhinol Laryngol 2006;115: 277-84.
66. Chen TC, Cense B, Pierce MC, et al. Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging. Arch Ophthalmol 2005;123:1715-20.
67. Schmidt-Erfurth U, Leitgeb RA, Michels S, et al. Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases. Invest Ophthalmol Vis Sci 2005;46:3393-402.
68. Schocket LS, Witkin AJ, Fujimoto JG, et al. Ultrahigh-resolution optical coherence tomography in patients with decreased visual acuity after retinal detachment repair. Ophthalmology 2006;113:666-72.
69. Sosnovik D, Weissleder R. Magnetic resonance and fluorescence based molecular imaging technologies. Prog Drug Res 2005;62:83-115.
70. Wilder-Smith P, Krasieva T, Jung WG, et al. Noninvasive imaging of oral premalignancy and malignancy. J Biomed Opt 2005;10:051601.
71. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983;220:524-7.
72. Anderson RR, Parrish JA. Microvasculature can be selectively damaged using dye lasers: a basic theory and experimental evidence in human skin. Lasers Surg Med 1981;1:263-76.
73. Anderson RR, Jaenicke KF, Parrish JA. Mechanisms of selective vascular changes caused by dye lasers. Lasers Surg Med 1983;3:211-5.
74. Zeitels SM, Akst LM, Burns JA, Hillman RE, Broadhurst MS, Anderson RR. Pulsed angiolytic laser treatment of ectasias and varices in singers. Ann Otol Rhinol Laryngol 2006; 115:571-80.
75. Franco RA Jr, Zeitels SM, Farinelli WA, Faquin W, Anderson RR. 585-nm Pulsed dye laser treatment of glottal dysplasia. Ann Otol Rhinol Laryngol 2003;112:751-8.
76. Randeberg LL, Bonesronning JH, Dalaker M, Nelson JS, Svaasand LO. Methemoglobin formation during laser induced photothermolysis of vascular skin lesions. Lasers Surg Med 2004;34:414-9.
77. Berg K, Selbo PK, Weyergang A, et al. Porphyrin-related photosensitizers for cancer imaging and therapeutic applications. J Microsc 2005;218:133-47.
78. Deliyski DD, Petrusheshev PP. Methods for objective assessment of high-speed videoendoscopy. In: 6th International Conference on Advances in Quantitative Laryngology. Hamburg, Germany: Universitatsklinikum Hamburg-Eppendorf, 2003.
79. Deliyski DD. Endoscope motion compensation for laryngeal high-speed videoendoscopy. J Voice 2005;19:485-96.
80. Schade G, Leuwer R, Kraas M, Rassow B, Hess MM. Laryngeal morphometry with a new laser "clip on" device. Lasers Surg Med 2004;34:363-7.
81. Kobler JB, Rosen DI, Burns JA, et al. Comparison of a flexible laryngoscope with calibrated sizing function to intraoperative measurements. Ann Otol Rhinol Laryngol 2006;115:733-40.
82. Ding LW, Wang HC, Wu HD, Chang CJ, Yang PC. Laryngeal ultrasound: a useful method in predicting post-extubation stridor. A pilot study. Eur Respir J 2006;27:384-9.
83. Vats A, Worley GA, de Bruyn R, Porter H, Albert DM, Bailey CM. Laryngeal ultrasound to assess vocal fold paralysis in children. J Laryngol Otol 2004;118:429-31.
84. Heaton JT, Kobler JB, Hillman RE, Zeitels SM. A new instrument for intraoperative assessment of individual vocal folds. Laryngoscope 2005;115:1223-9.
85. Chan RW. Measurements of vocal fold tissue viscoelasticity: approaching the male phonatory frequency range. J Acoust Soc Am 2004;115:3161-70.
86. Gunter HE, Howe RD, Zeitels SM, Kobler JB, Hillman RE. Measurement of vocal fold collision forces during phonation: methods and preliminary data. J Speech Lang Hear Res 2005;48:567-76.
87. Gunter HE. A mechanical model of vocal-fold collision with high spatial and temporal resolution. J Acoust Soc Am 2003;113:994-1000.
88. Gunter HE. Modeling mechanical stresses as a factor in the etiology of benign vocal fold lesions. J Biomech 2004;37: 1119-24.
89. Cheyne HA, Hanson HM, Genereux RP, Stevens KN, Hillman RE. Development and testing of a portable vocal accumulator. J Speech Lang Hear Res 2003;46:1457-67.
90. Hillman RE, Heaton JT, Masaki A, Zeitels SM, Cheyne HA. Ambulatory monitoring of disordered voices. Ann Otol Rhinol Laryngol 2006;115:795-801.
91. Popolo PS, Svec JG, Titze IR. Adaptation of a Pocket PC for use as a wearable voice dosimeter. J Speech Lang Hear Res 2005;48:780-91.
92. Kreiman J, Gerratt BR, Kempster GB, Erman A, Berke GS. Perceptual evaluation of voice quality: review, tutorial, and a framework for future research. J Speech Hear Res 1993;36:21-40.
93. Titze IR. Summary statement. In: Workshop on Acoustic Voice Analysis. Denver, Colo: National Center for Voice and Speech, 1995.
94. Hillman RE, Montgomery WW, Zeitels SM. Current diagnostics and office practice: use of objective measures of vocal function in the multidisciplinary management of voice disorders. Curr Opin Otolaryngol Head Neck Surg 1997;5:172-5.
95. Shrivastav R, Sapienza CM, Nandur V. Application of psychometric theory to the measurement of voice quality using rating scales. J Speech Lang Hear Res 2005;48:323-35.
96. Gerratt BR, Kreiman J. Measuring vocal quality with speech synthesis. J Acoust Soc Am 2001;110:2560-6.
97. Zhang Y, Jiang JJ, Wallace SM, Zhou L. Comparison of nonlinear dynamic methods and perturbation methods for voice analysis. J Acoust Soc Am 2005;118:2551-60.
98. Hillman RE, Walsh MJ, Wolf GT, et al. Functional outcomes following treatment for advanced laryngeal cancer. Part I - Voice preservation in advanced laryngeal cancer. Part II - Laryngectomy rehabilitation: the state of the art in the VA system. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group. Ann Otol Rhinol Laryngol Suppl 1998;107(suppl 172).
99. Meltzner G, Hillman RE, Heaton JT, Houston KM, Kobler JB, Qi Y. Electrolaryngeal speech: the state of the art and future directions for development. In: Keith P, ed. Contemporary considerations in the treatment and rehabilitation of head and neck cancer. Austin, Tex: Pro-Ed, 2005:571-92.
100. Heaton JT, Goldstein EA, Kobler JB, et al. Surface electromyographic activity in total laryngectomy patients following laryngeal nerve transfer to neck strap muscles. Ann Otol Rhinol Laryngol 2004;113:754-64.
101. Goldstein EA, Heaton JT, Kobler JB, Stanley GB, Hillman RE. Design and implementation of a hands-free electrolarynx device controlled by neck strap muscle electromyographic activity. IEEE Trans Biomed Eng 2004;51:325-32.
102. Meltzner GS, Hillman RE. Impact of aberrant acoustic properties on the perception of sound quality in electrolarynx speech. J Speech Lang Hear Res 2005;48:766-79.